Skip to main content
. 2013 Mar 4;5(5):1467–1476. doi: 10.3892/ol.2013.1224

Table IV.

Survival rates.

DFS rate (%)
OS rate (%)
P-value
Cases Frequency (n/total, %) 2-year 5-year 2-year 5-year Recurrence rate (%) Metastasis rate (%) Mortality rate (%) DFS OS
Available total 50, 100 66.2 51.3 88.6 88.6 40 16 10 - -
Surgery alone 23/50, 46 67.4 56.2 84.7 84.7 34.8 0 8.7 0.5513 0.7193
Surgery + RT/ChT 26/50, 52 73.8 66.4 91.4 91.4 46.2 30.8 7.7
Size <4 cm 23/35, 66 81.5 - 100 - 17.4 0 0 0.0446 0.0086
Size ≤4 cm 12/35, 34 36.8 36.8 59.7 59.7 58.3 8.3 33.3
Tonsil 27/52, 52 95.8 66.4 95.3 88.6 30.8 15.4 3.9 - -
Parapharyngeal space 10/52, 19 40.0 40.0 95.3 88.6 80 20 30 - -
Nasopharynx 8/52, 15 71.4 71.4 95.3 88.6 37.5 12.5 12.5 - -
Palate 4/52, 8 100 100 95.3 88.6 0 0 0 - -
Pharynx 2/52, 4 50.0 50.0 95.3 88.6 50 50 0 - -

RT, radiotherapy; ChT, chemotherapy; -, not available; LR, local recurrence; DM, distant metastasis; DFS, disease free survival; OS, overall survival.